Position in ALVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,552,200
+$9,867,315 QoQ
Shares Held
2,859,675
+1332.2% QoQ
Ownership
0.801%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#5
of 72 holders
Holding Since
Jun 2022
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FARALLON CAPITAL MANAGEMENT LLC holds $1,298,300,139 across 5 Drug Manufacturers - Specialty & Generic names. ALVO ranks #3 (0.8% of the industry book) .
All Filings in ALVO
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,552,200 | 2,859,675 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $684,885 | 199,675 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $1,024,332 | 199,675 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,635,338 | 199,675 | Shares | Other | 2026-02-17 | |
| 2025-06-30 | $1,821,036 | 199,675 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $1,930,857 | 199,675 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $2,641,700 | 199,675 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $2,376,132 | 199,675 | Shares | Other | 2024-11-14 | |
| 2023-06-30 | $3,383,231 | 437,110 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $6,450,000 | 500,000 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $5,000,000 | 500,000 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $3,380,000 | 500,000 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $4,105,000 | 500,000 | Shares | Other | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||